Ocera Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease.
| Website: | www.ocerainc.com |
| Main Phone: | +1 650 475-0158 |
| Address: | 525 University Avenue |
| Address 2: | Suite 610 |
| State: | CA |
| City / Town: | Palo Alto |
| Country: | USA |
| Postal Code: | 94301 |
| Exchange: | NSD |
| Employees: | 20 |
| NAICS: | Pharmaceutical P |
| Last Price 1.08 | Change $ 0.0967 | Change % 9.83 | Tick N/A |
| Bid 1.06 | Bid Size 1,000.00 | Ask 1.08 | Ask Size 2,700.00 |
| Open 1.00 | High 1.09 | Low 1.00 | Prev Close 0.98 |
| Last Trade | Volume 303,136 | 52 Wk Hi 3.15 | 52 Wk Low 0.52 |
| Market Cap 28.6 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 26,510,051.00 | EPS (TTM) -1.04 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 1 | 8 |
| Number of Buys | 1 | 7 |
| Number of Sells | 0 | 1 |
| Net Activity | 11969 | 48469 |
| Last 10 Buys | Shares |
|---|---|
| Linda S. Grais | 1,000 |
| Linda S. Grais | 1,000 |
| Michael Byrnes | 1,000 |
| Linda S. Grais | 1,000 |
| Gaurav Aggarwal | 1,000 |
| Wendell D. Wierenga | 1,000 |
| Rajiv Patni | 1,000 |
| Linda S. Grais | 1,000 |
| Gaurav Aggarwal | 1,000 |
| Michael Byrnes | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 11 | 11 | 11 | 11 |
| Low Target Price Estimate | 10 | 10 | 10 | 10 |
| Mean Target Price Estimate | 10.67 | 10.67 | 10.67 | 10.67 |
| Standard Deviation | 0.58 | 0.58 | 0.58 | 0.58 |
| Date of Most Recent Estimate | 08/03/16 | 08/03/16 | 05/06/16 | 08/03/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 30 | 2016-08-04 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2016-08-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-06-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-15 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
